Michael Adam Gordon is General Counsel and Secretary of Lucid Diagnostics Inc.. Currently has a direct ownership of 700,000 shares of LUCD, which is worth approximately $1.08 Million. The most recent transaction as insider was on Feb 20, 2025, when has been sold 300,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 700K
75.0% 3M change
n/a 12M change
Total Value Held $1.08 Million

Michael Adam Gordon Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 20 2025
BUY
Grant, award, or other acquisition
-
300,000 Added 30.0%
700,000 Common Stock
May 07 2024
BUY
Grant, award, or other acquisition
-
400,000 Added 50.0%
400,000 Common Stock

Also insider at

PAVM
PAVmed Inc. Healthcare
MAG

Michael Adam Gordon

General Counsel and Secretary
New York, NY

Track Institutional and Insider Activities on LUCD

Follow Lucid Diagnostics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LUCD shares.

Notify only if

Insider Trading

Get notified when an Lucid Diagnostics Inc. insider buys or sells LUCD shares.

Notify only if

News

Receive news related to Lucid Diagnostics Inc.

Track Activities on LUCD